Imitrex Patent Settlement Allows For Entry During Pediatric Exclusivity Period
This article was originally published in The Pink Sheet Daily
Executive Summary
Spectrum/Par say launch of subcutaneous sumatriptan could come as early as Aug. 6, 2008.